ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins
| | | | | Tissue enhanced |
ANLN | Anillin, actin binding protein | | | | | | Tissue enhanced |
AP3B2 | Adaptor-related protein complex 3, beta 2 subunit | | | | | | Tissue enhanced |
APBA1 | Amyloid beta (A4) precursor protein-binding, family A, member 1 | | | | | | Tissue enhanced |
ARC | Activity-regulated cytoskeleton-associated protein | | | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
ASPHD1 | Aspartate beta-hydroxylase domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
B3GNT1 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT4 | Beta-1,4-N-acetyl-galactosaminyl transferase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
BASP1 | Brain abundant, membrane attached signal protein 1 | Cytoskeleton related proteins Plasma proteins Transporters
| | | | | Tissue enhanced |
BCAS1 | Breast carcinoma amplified sequence 1 | | | | | | Tissue enhanced |
BHLHE22 | Basic helix-loop-helix family, member e22 | Transcription factors
| | | | | Tissue enhanced |
C2orf82 | Chromosome 2 open reading frame 82 | Predicted membrane proteins
| | | | | Tissue enhanced |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CADPS | Ca++-dependent secretion activator | Plasma proteins
| | | | | Tissue enhanced |
CCSAP | Centriole, cilia and spindle-associated protein | | | | | | Tissue enhanced |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CHADL | Chondroadherin-like | Predicted secreted proteins
| | | | | Tissue enhanced |
CHL1 | Cell adhesion molecule L1-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN11 | Claudin 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
CNTN1 | Contactin 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CORO2B | Coronin, actin binding protein, 2B | Plasma proteins
| | | | | Tissue enhanced |
CPE | Carboxypeptidase E | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRB2 | Crumbs homolog 2 (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTXN2 | Cortexin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
DCLK1 | Doublecortin-like kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DCLK2 | Doublecortin-like kinase 2 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
DNAH10OS | Dynein, axonemal, heavy chain 10 opposite strand | | | | | | Tissue enhanced |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
DYNC1I1 | Dynein, cytoplasmic 1, intermediate chain 1 | | | | | | Tissue enhanced |
FAM169A | Family with sequence similarity 169, member A | | | | | | Tissue enhanced |
FAM19A2 | Family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 | Predicted secreted proteins
| | | | | Tissue enhanced |
FAM81A | Family with sequence similarity 81, member A | | | | | | Tissue enhanced |
FSD1 | Fibronectin type III and SPRY domain containing 1 | | | | | | Tissue enhanced |
GDA | Guanine deaminase | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GLDN | Gliomedin | | | | | | Tissue enhanced |
GNG13 | Guanine nucleotide binding protein (G protein), gamma 13 | RAS pathway related proteins
| | | | | Tissue enhanced |
GPR123 | G protein-coupled receptor 123 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR162 | G protein-coupled receptor 162 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPR61 | G protein-coupled receptor 61 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPRC5B | G protein-coupled receptor, family C, group 5, member B | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
HEPACAM | Hepatic and glial cell adhesion molecule | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
HOMER1 | Homer homolog 1 (Drosophila) | | | | | | Tissue enhanced |
HS6ST3 | Heparan sulfate 6-O-sulfotransferase 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
IGSF21 | Immunoglobin superfamily, member 21 | Predicted secreted proteins
| | | | | Tissue enhanced |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNIP3 | Kv channel interacting protein 3, calsenilin | Predicted secreted proteins
| | | | | Tissue enhanced |